$100 million Investment in Medical Manufacturing

Edwards Lifesciences has announced that as part of the expansion plan for its operations in Costa Rica, it will start construction of a new heart valve manufacturing plant in Cartago.

Thursday, November 2, 2017

The company dedicated to the manufacture of heart valves started construction of the new plant next to the current one, located in the Zona Franca La Lima, in Cartago. Heart valve devices will be manufactured in the new facilities, "... from beginning to end, that is to say, they will be totally manufactured in Costa Rica."

Cinde's statement points out that "... In order to make progress with the expansion plans, construction recently started of the new plant on a plot of land measuring approximately 20,000 m2, also located in the La Lima de Cartago Free Zone. The new plant is expected to be fully operational in 2020 parallel to the current production plant."

See "Costa Rica: More investment in medical manufacturing"

"... The company, based in California, United States, develops and manufactures heart valves that are used in treatment of patients with heart disease worldwide. The company has been operating in La Lima de Cartago Free Zone since 2016 and currently has more than 200 employees in the country. To date, the company, from its site in Cartago, supports the heart valve manufacturing process that takes place at other Edwards Lifesciences sites in the United States and other countries around the world."

Do you need more information about your business sector?

Request more information:









this site is protected by reCAPTCHA and Google's privacy policy and terms of service.
Need assistance? Contact us
(506) 4001-6423


More on this topic

Medical Devices: New Plant in Costa Rica

October 2019

After investing $100 million, Edwards Lifesciences opened its second heart valve manufacturing plant in La Lima, Cartago.

The 24,455-square-meter industrial plant is located in the La Lima Free Zone industrial park, according to the Costa Rican Coalition of Development Initiatives (Cinde).

More Investment in Medical Device Manufacturing

May 2018

In Costa Rica, the manufacturer of medical devices for continence and ostomy, Coloplast, has announced that it will be building a manufacturing plant in La Lima free zone, in Cartago.

The company of Danish origin reported that " ...In January 2019, Coloplast will start operating in a temporary location, located next to what will be its new manufacturing plant. This will create the organizational bases for future expansion and let us get to know the local business environment."

Costa Rica: $10 Million for Medical Devices

June 2016

Edwards Lifesciences Corporation has announced it is to build a heart valve production plant in Cartago which will start operating in early 2017.

From a statement issued by the Ministry of Foreign Trade:

The company Edwards Lifesciences Corporation, a global leader in innovations designed to address heart disease and monitor patients in critical condition today announced that it has chosen Costa Rica as the country in which to expand its production network of heart valves, with an investment of $10 million (around ₡5 billion).

Certified Contraceptive Produced in Costa Rica

August 2015

The permanent birth control device is being manufactured in the new plant that Bayer Medical started up in 2014, after making an investment of $12 million.

The plant began operating after the German company bought the assets of Conceptus, which included a patent for an inter-uterine contraceptive device to be manufactured in Costa Rica.